NASDAQ: VRSA
Versabank Stock

$20.67-1.54 (-6.93%)
Updated Nov 19, 2026
VRSA Price
$20.67
Fair Value Price
$12.25
Market Cap
$670.10M
52 Week Low
$11.31
52 Week High
$25.00
P/E
27.16x
P/B
1.63x
P/S
6.05x
PEG
7.98x
Dividend Yield
0.35%
Revenue
$104.64M
Earnings
$24.17M
Gross Margin
100%
Operating Margin
34.25%
Profit Margin
23.5%
Debt to Equity
11.16
Operating Cash Flow
$11M
Beta
0.6
Next Earnings
Dec 9, 2026
Ex-Dividend
N/A
Next Dividend
N/A

VRSA Overview

VersaBank offers banking products and services in Canada. Deposit products include guaranteed investment certificates, registered retirement savings plans, daily interest savings accounts, and tax-free savings accounts. The company also purchases loan and lease receivables from finance companies. It also offers commercial banking services and residential mortgages. VersaBank was incorporated in 1979 and is headquartered in London, Ontario, Canada.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine VRSA's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Bank

Industry Rating
C
VRSA
Ranked
#164 of 298

Top Ranked Stocks in Industry

View Top Bank Stocks

Be the first to know about important VRSA news, forecast changes, insider trades & much more!

VRSA News

Overview

Due Diligence Score

–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VRSA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VRSA ($20.67) is overvalued by 68.69% relative to our estimate of its Fair Value price of $12.25 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
VRSA ($20.67) is not significantly undervalued (68.69%) relative to our estimate of its Fair Value price of $12.25 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
VRSA ($20.67) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more VRSA due diligence checks available for Premium users.

Valuation

VRSA fair value

Fair Value of VRSA stock based on Discounted Cash Flow (DCF)

Price
$20.67
Fair Value
$12.25
Overvalued by
68.69%
VRSA ($20.67) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VRSA ($20.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VRSA ($20.67) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VRSA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
27.16x
Industry
12.77x
Market
41.92x
VRSA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VRSA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

VRSA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.63x
Industry
1.31x
VRSA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VRSA price to earnings growth (PEG)

For valuing profitable companies with growth potential

VRSA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

VRSA's financial health

Profit margin

Revenue
$27.7M
Net Income
$7.2M
Profit Margin
25.9%
VRSA's Earnings (EBIT) of $35.84M... subscribe to Premium to read more.
Interest Coverage Financials
VRSA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.9B
Liabilities
$4.5B
Debt to equity
11.16
VRSA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
VRSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$31.9M
Investing
-$22.5M
Financing
$1.9M
VRSA's operating cash flow ($11.61M)... subscribe to Premium to read more.
Debt Coverage Financials

VRSA vs Bank Stocks

TickerZen RatingMarket Cap1d %P/EP/B
VRSAC$670.10M-6.93%27.16x1.63x
BCALC$673.22M-1.17%11.62x1.16x
RRBIC$674.21M-0.61%14.12x1.76x
CBNK–$664.02M-1.48%12.20x1.54x
BHBC$661.92M-1.89%11.65x1.24x

Versabank Stock FAQ

What is Versabank's quote symbol?

(NASDAQ: VRSA) Versabank trades on the NASDAQ under the ticker symbol VRSA. Versabank stock quotes can also be displayed as NASDAQ: VRSA.

If you're new to stock investing, here's how to buy Versabank stock.

What is the 52 week high and low for Versabank (NASDAQ: VRSA)?

(NASDAQ: VRSA) Versabank's 52-week high was $25.00, and its 52-week low was $11.31. It is currently -17.32% from its 52-week high and 82.76% from its 52-week low.

How much is Versabank stock worth today?

(NASDAQ: VRSA) Versabank currently has 32,419,079 outstanding shares. With Versabank stock trading at $20.67 per share, the total value of Versabank stock (market capitalization) is $670.10M.

Versabank stock was originally listed at a price of $11.05 in Sep 23, 2021. If you had invested in Versabank stock at $11.05, your return over the last 5 years would have been 87.06%, for an annualized return of 13.34% (not including any dividends or dividend reinvestments).

How much is Versabank's stock price per share?

(NASDAQ: VRSA) Versabank stock price per share is $20.67 today (as of Nov 19, 2026).

What is Versabank's Market Cap?

(NASDAQ: VRSA) Versabank's market cap is $670.10M, as of Nov 20, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Versabank's market cap is calculated by multiplying VRSA's current stock price of $20.67 by VRSA's total outstanding shares of 32,419,079.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.